Indian pharmaceutical industry, it is argued, has democratized the availability, accessibility and affordability of medicines. Everyone, rich or poor, can now get them at a fraction of the cost of branded drugs. However, the allegations about their suspect quality, if true, pose questions of life-and-death for the unsuspecting consumers. Is it the messiah supplying the low-cost quality medicines across the globe or is it the precursor for the ultimate indigence of the unsuspecting millions consuming poor-quality generic medicines? In the absence of any evidence, it remains an inexplicable enigma. This book by a public policy practitioner of four decades who steered drug regulation in the Government of India unravels the truth.